← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$313K

Shares

55,000

Price

$6

Filed

Apr 7

Insider

Name

Townsend Richard Nolan

Title

Chief Executive Officer

CIK

0001995218

Roles

Director Officer

Transaction Details

Transaction Date

2026-04-06

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

340,106

Footnotes

The sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. | This transaction was executed in multiple trades at prices ranging from $5.56 to $5.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Includes 261,349 Restricted Stock Units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Filing Info

Accession No.

0001995218-26-000009

Form Type

4

Issuer CIK

0001907108

Townsend Richard Nolan's History

Date Ticker Type Value
2026-04-06 LXEO $313K
2025-11-18 LXEO $10K
2025-10-17 LXEO $116K
2025-10-17 LXEO $1K
2025-10-15 LXEO A $0
2025-09-12 LXEO A $6K
2025-08-18 LXEO $13K
2025-08-18 LXEO $5K
2025-05-16 LXEO $3K

Other Insiders at LXEO (90d)

No other insider activity at this issuer in the last 90 days.